As shown in Figure 4b, adding of z-VAD-fmk, a pan-caspase inhibitor, apparently inhibited the increase in the percentages of Annexin V+ cells in poly(I:C)-transfected RCC cells. Here, ANXA5 is linked to renal cell carcinoma.